Key Takeaways
- • DXC Technology trades at a 2.4x EV/EBITDA with $1.036 billion in FY26 operating cash flow against a $1.6 billion market cap, presenting a deep-value entry point for leveraged buyout sponsors; potential acquirers include Apollo or Silver Lake, with the Insurance Software & Services unit (growing +20.3% in bookings) positioned as a carve-out candidate.
- • Genpact generates $734.7 million in FY25 free cash flow with a trailing P/E of 9x and beta of 0.618, trading 30.7% below analyst targets; its Business Process Outsourcing contract base provides stable cash generation while Advanced Technology Solutions (growing +24.3% in Q1) offers a high-margin acceleration opportunity for a sponsor.
- • Both candidates demonstrate the core LBO thesis: predictable free cash flow to service acquisition debt, depressed valuations relative to intrinsic value, underleveraged balance sheets, and clear operational levers for value creation post-acquisition.
- • CEO management actions—including DXC's Raul Fernandez reducing net debt by $1.1 billion over two years—signal operational discipline and balance sheet strength, reducing refinancing risk in a PE transaction structure.
Summary
Private equity sponsors evaluate leveraged buyout targets through a disciplined framework: predictable free cash flow generation to service acquisition debt, compressed valuations relative to earnings or revenue, balance sheets with deleveraging capacity, identifiable operational improvements, and market capitalizations aligned with fund deployment mandates. Two mid-cap names highlighted by 24/7 Wall St. analysis meet these criteria with particular clarity as of late July 2026.
DXC Technology exemplifies the deep-value profile. Trading at $10.05 per share (down 31.1% over the past year), the technology services company carries a market capitalization of approximately $1.6 billion against an enterprise value-to-EBITDA multiple of 2.4x and a price-to-sales ratio of 0.12—both at levels typically associated with distressed or heavily discounted assets. The company's FY26 operating cash flow of $1.036 billion against a sub-$2 billion equity value yields the kind of cash-on-cash returns that attract sponsor capital. CEO Raul Fernandez has demonstrated operational discipline by shrinking net debt by $1.1 billion over a two-year period, reducing refinancing risk. The Insurance Software & Services unit, growing bookings at +20.3%, represents a natural carve-out opportunity for a strategic buyer or secondary sponsor. Potential acquirers identified include Apollo Global Management and Silver Lake Partners. A headwind: organic revenue declined 6.6% in Q4, and insider selling in mid-May at prices as low as $8.94 signals insider caution.
Genpact presents a complementary profile with stronger growth dynamics. Shares at $31.26 have declined 30.7% over the past year, well below analyst consensus of $39.27, creating valuation disconnects. The company carries a trailing price-to-earnings multiple of 9x with a beta of just 0.618, indicating lower volatility relative to the broader market. Genpact's Business Process Outsourcing contract base generated $812.9 million in operating cash flow, with FY25 free cash flow of $734.7 million, providing consistent debt service capacity. The company's Advanced Technology Solutions segment grew 24.3% in Q1 and now represents 27% of total revenue—a high-margin growth engine that a sponsor could accelerate through investment or operational scaling. Genpact carries PE-friendly DNA, having been spun out of General Electric through Bain Capital and General Atlantic, suggesting familiarity with institutional ownership structures.
Both companies satisfy the core LBO checklist: predictable cash generation, depressed valuations, balance sheet capacity, and identifiable value creation levers. Market conditions in mid-2026, with elevated VIX signals and broad equity market stress, have compressed valuations across mid-cap names, potentially opening deployment windows for sponsors with dry powder seeking entry points at below-consensus valuations.
DXC Technology exemplifies the deep-value profile. Trading at $10.05 per share (down 31.1% over the past year), the technology services company carries a market capitalization of approximately $1.6 billion against an enterprise value-to-EBITDA multiple of 2.4x and a price-to-sales ratio of 0.12—both at levels typically associated with distressed or heavily discounted assets. The company's FY26 operating cash flow of $1.036 billion against a sub-$2 billion equity value yields the kind of cash-on-cash returns that attract sponsor capital. CEO Raul Fernandez has demonstrated operational discipline by shrinking net debt by $1.1 billion over a two-year period, reducing refinancing risk. The Insurance Software & Services unit, growing bookings at +20.3%, represents a natural carve-out opportunity for a strategic buyer or secondary sponsor. Potential acquirers identified include Apollo Global Management and Silver Lake Partners. A headwind: organic revenue declined 6.6% in Q4, and insider selling in mid-May at prices as low as $8.94 signals insider caution.
Genpact presents a complementary profile with stronger growth dynamics. Shares at $31.26 have declined 30.7% over the past year, well below analyst consensus of $39.27, creating valuation disconnects. The company carries a trailing price-to-earnings multiple of 9x with a beta of just 0.618, indicating lower volatility relative to the broader market. Genpact's Business Process Outsourcing contract base generated $812.9 million in operating cash flow, with FY25 free cash flow of $734.7 million, providing consistent debt service capacity. The company's Advanced Technology Solutions segment grew 24.3% in Q1 and now represents 27% of total revenue—a high-margin growth engine that a sponsor could accelerate through investment or operational scaling. Genpact carries PE-friendly DNA, having been spun out of General Electric through Bain Capital and General Atlantic, suggesting familiarity with institutional ownership structures.
Both companies satisfy the core LBO checklist: predictable cash generation, depressed valuations, balance sheet capacity, and identifiable value creation levers. Market conditions in mid-2026, with elevated VIX signals and broad equity market stress, have compressed valuations across mid-cap names, potentially opening deployment windows for sponsors with dry powder seeking entry points at below-consensus valuations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.